Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 NDC API, 1 Listed Suppliers

1 API Suppliers
1 NDC API
1 Listed Suppliers

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 14197-60-5, 20s-ginsenoside rg3, (20s)-propanaxadiol, 20s-propanaxadiol, (20s)-ginsenoside rg3, S-ginsenoside rg3

Molecular Formula

C₄₂H₇₂O₁₃

Molecular Weight

785.0 g/mol

InChI Key

RWXIFXNRCLMQCD-JBVRGBGGSA-N

FDA UNII

227D367Y57

ginsenoside rg3 is a natural product found in Panax ginseng, Panax notoginseng, and other organisms with data available.

1 2D Structure

Ginsenoside Rg3

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

2.1.2 InChI

InChI=1S/C42H72O13/c1-21(2)10-9-14-42(8,51)22-11-16-41(7)29(22)23(45)18-27-39(5)15-13-28(38(3,4)26(39)12-17-40(27,41)6)54-37-35(33(49)31(47)25(20-44)53-37)55-36-34(50)32(48)30(46)24(19-43)52-36/h10,22-37,43-51H,9,11-20H2,1-8H3/t22-,23+,24+,25+,26-,27+,28-,29-,30+,31+,32-,33-,34+,35+,36-,37-,39-,40+,41+,42-/m0/s1

2.1.3 InChI Key

RWXIFXNRCLMQCD-JBVRGBGGSA-N

2.1.4 Canonical SMILES

CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)O)C

2.1.5 Isomeric SMILES

CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O)C)O)C

2.2 Other Identifiers

2.2.1 UNII

227D367Y57

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 20(r)-ginsenoside Rg(3)

2. 20(s)-ginsenoside Rg(3)

3. 20s-ginsenoside Rg3

4. 3-o-beta-d-glucopyranosyl-(1->2)-beta-d-glucopyranosyldammar-24-ene-3beta,12beta,20s-triol

5. Beta-d-glucopyranoside, (3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-

6. Ginsenoside 20-rg3

7. Ginsenoside Rg(3)

8. Ginsenoside Rg3, (+)-

9. Ginsenoside Rg3, (s)-

10. S-ginsenoside Rg3

2.3.2 Depositor-Supplied Synonyms

1. 14197-60-5

2. 20s-ginsenoside Rg3

3. (20s)-propanaxadiol

4. 20s-propanaxadiol

5. (20s)-ginsenoside Rg3

6. S-ginsenoside Rg3

7. 20(s)-ginsenoside Rg3

8. 20(s)-ginsenoside-rg3

9. 20(s)-propanaxidiol

10. Chembl398412

11. Chebi:67991

12. (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-4,5-dihydroxy-2-[[(3s,5r,8r,9r,10r,12r,13r,14r,17s)-12-hydroxy-17-[(2s)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

13. 11019-45-7

14. 227d367y57

15. (r)ginsenoside-rg3

16. Ginsenoside 20-rg3

17. Ginsenoside Rg3, (s)-

18. Ginsenoside Rg3, (+)-

19. Unii-227d367y57

20. Rg3

21. Mfcd06410950

22. Ginsenoside Rg3,(s)

23. 2'(r)-ginsenoside-rg3

24. Gtpl7658

25. Ginsenoside Rg3 [who-dd]

26. Dtxsid101316982

27. Hms3886b14

28. Bdbm50317537

29. Ginsenoside Rg3, Analytical Standard

30. S9022

31. Zinc96085900

32. Ginsenoside Rg3, >=98% (hplc)

33. Akos037514674

34. Ccg-270472

35. (3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-beta-d-glucopyranoside

36. As-56617

37. Dammar-24-ene-12-beta,20-diol, 3-beta-((2-o-beta-d-glucopyranosyl-beta-d-glucopyransoyl)oxy)-

38. C20778

39. 197g605

40. Q-100154

41. Q27077807

42. .beta.-d-glucopyranoside, (3.beta.,12.beta.)-12,20-dihydroxydammar-24-en-3-yl 2-o-.beta.-d-glucopyranosyl-

43. 3-o-.beta.-d-glucopyranosyl-(1->2)-.beta.-d-glucopyranosyldammar-24-ene-3.beta.,12.beta.,20s-triol

44. Beta-d-glucopyranoside, (3-beta,12-beta)-12,20-dihydroxydammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-

45. Dammar-24-ene-12beta,20-diol, 3-beta-((2-o-beta-d-glucopyranosyl-beta-d-glucopyransoyl)oxy)-

2.4 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₄₂H₇₂O₁₃
Molecular Weight	785.0 g/mol
XLogP3	4
Hydrogen Bond Donor Count	9
Hydrogen Bond Acceptor Count	13
Rotatable Bond Count	10
Exact Mass	784.49729235 g/mol
Monoisotopic Mass	784.49729235 g/mol
Topological Polar Surface Area	219 Å²
Heavy Atom Count	55
Formal Charge	0
Complexity	1370
Isotope Atom Count	0
Defined Atom Stereocenter Count	20
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Antineoplastic Agents, Phytogenic

Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)

API SUPPLIERS